Targeting non-cancerous cells in tumours could open up new frontiers in fight against the disease
Scientists hope to double the survival rate of people with advanced cancer within a decade by using new lines of attack to fight the disease.
Speaking at the launch of a joint five-year research strategy by the Institute of Cancer Research (ICR) and the Royal Marsden NHS foundation trust in London, experts described how targeting non-cancerous cells within tumours could open up new frontiers in the fight against the disease, enabling more people to be cured and others to survive for far longer.
